Fiche centre
IRCCS San Raffaele Roma
Roma — Italy
Essais liés3clinical trials
VilleRomalocalisation
PaysItalylocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT05570149
Essais cliniques associés
3| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Rimegepant | Migraine | Phase 3 | NCT06641466 | A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine | RECRUITING |
| Rimegepant | Migraine | Phase 3 | NCT06616194 | A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent Migraine | ACTIVE_NOT_RECRUITING |
| Eptinezumab 100 mg or Eptinezumab 300 mg administered intravenously in 100 mL saline solution | Migraine | À vérifier | NCT05570149 | EMBRACE — EptinezuMaB in ReAl-world evidenCE: Multicenter, Real Life, Cohort Study in Migraine. | RECRUITING |